---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-085921"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2024-10-07T23:59:59+00:00"
generated_at: "2026-05-30T19:37:47.554582+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Denali Capital Acquisition receives Nasdaq deficiency notice for non-compliance with listing rules

## Summary
- Nasdaq notified Denali on Oct 2, 2024 of non-compliance with MVLS ($50M minimum) and Total Assets rules for Nasdaq Global Market.
- Company has 180 days, until March 31, 2025, to regain compliance by meeting MVLS >= $50M for 10 consecutive business days.
- No immediate delisting; securities continue trading on Nasdaq; management is evaluating options to regain compliance.
- Failure to comply by deadline may result in a delisting notice with opportunity to appeal to a Nasdaq Hearing Panel.

## SEC filing metadata
- accession: 0001213900-24-085921
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2024-10-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390024085921/0001213900-24-085921-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024085921/ea0216758-8k425_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-085921
- JSON: https://secwatch.observer/filing/0001213900-24-085921.json
- Plain text: https://secwatch.observer/filing/0001213900-24-085921.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.